However, Sanofi will need to prove its effectiveness in comparison to the newer, more versatile GLP-1 drugs in the market
Safety and Monitoring Both NAD+ and BPC-157 have strong safety profiles when administered under clinical supervision
You will see the specific eligibility criteria for each trial, which typically include BMI thresholds, age ranges, and exclusion criteria around existing conditions or medications
Other ingredients Gelatin capsule, corn starch, microcrystalline cellulose, organic rice extract blend (organic rice extract, organic rice hulls, organic gum arabic, organic sunflower oil), magnesium stearate (vegetable source), silica
Consult a licensed physician to determine which option, if any, is appropriate for your individual situation